Dr. Kathy Sam, MD

Dr. Sam practices at Oncology Consultants, P. A. in Houston, Texas.

Dr. Sam's NPI, 1427203819, was assigned on November 26, 2008. Dr. Sam graduated from Baylor College Of Medicine in 2006. Dr. Sam holds Texas license P3812.

Dr. Sam's primary practice is Oncology Consultants, P. A., at 1140 Business Center Dr, Houston, TX 77043 in Harris County. The practice phone is (713) 827-9525.

Dr. Sam's primary practice is Oncology Consultants, P. A. in Houston, Texas. Dr. Sam is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Sam to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sam practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sam's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sam is board certified in medical oncology by the American Board of Internal Medicine. Dr. Sam is licensed in Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Sam treats.

CMS data shows 42,194 Medicare services from Dr. Sam across 23 procedure codes in 2024, for 252 Medicare patients. Medicare paid $157,657 for them. Every service was in an office.

CMS counts 252 Medicare patients who saw Dr. Sam in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sam's median patient age at 69, with 70% women.

In 2024, Dr. Sam wrote 2,752 Medicare Part D claims for 410 patients. 67% of them were for generic drugs. CMS names the drug for 2,450 of them, across 61 drugs with 11 or more claims each, at $7,999,986 in total drug cost. In 2023, CMS named 2,566 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Sam for performance year 2024, reported as part of a group. Dr. Sam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sam as offering telehealth.

Dmand AI links 2 papers to Dr. Sam in 2008. Dr. Sam's most frequent co-authors are Jenny C. Chang, MD, Richard Elledge, MD and Brendan H L Lee, MD, PhD.

CMS Open Payments shows 1,650 general payments to Dr. Sam from 97 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Bristol-Myers Squibb Company paid the most, $2,397.

Dr. Sam graduated from Baylor College Of Medicine in 2006.

Dr. Sam is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.